Anne-Sophie Kubasch

15PUBLICATIONS
116CO-AUTHORS
Haematological tumoursMedical mycologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 16, 2026
Canakinumab or emavusertib for anemia in lower-risk MDS: results of the CANFIRE and LUCAS phase 2, open-label, multicenter trials.

|Jul 17, 2026
Comprehensive analysis of prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q.

|Apr 30, 2026
How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?

|Mar 27, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia.

Luca Lanino, Anthony M Hunter, Nico Gagelmann

|Jun 25, 2025
IPSS-M risk and specific sex-associated somatic mutations predict response to ESA therapy in LR-MDS: building a new score.

Marco G Raddi, Sophie Park, Michaela Fontenay

|Aug 05, 2024
Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study.

Elena Crisà, Elvira Mora, Ulrich Germing

Pageof 3

Frequent Collaborators

11 joint publications

Uwe Platzbecker

7 joint publications

Klaus H Metzeler

5 joint publications

Valeria Santini

4 joint publications

Rami S Komrokji